U.S. Surgeon General Dr. Vivek Murthy informed CNBC on Wednesday there is reason to be confident that individuals who got the single-shot Johnson & & Johnson Covid-19 vaccine might be safeguarded versus the infection delta variant.Murthy indicated data that showed the Oxford-AstraZeneca shot is extremely efficient against hospitalization from the more contagious version. He also said people must think about the AstraZeneca vaccine “as a cousin” to J&Js shot since it was “developed on a similar platform.””While we are still awaiting direct research studies of Johnson & & Johnson and the delta version, we have reasons to be hopeful, since the J&J vaccine has actually proven to be quite efficient against preventing hospitalizations and deaths, with all the variants that weve seen to date,” Murthy told “The News with Shepard Smith.”World Health Organization authorities advised totally vaccinated people to continue to use masks, social distance and practice other pandemic-related safety procedures as the delta variant spreads around the world. The Centers for Disease Control and Prevention, however, affirmed Wednesday that its leaving it up to states and local health officials to set guidelines around mask-wearing. Murthy stated the CDC guidance was based on giving individuals flexibility.”The CDC, in its guidance, essentially, was giving people versatility and option but desired people to know that, if you are totally immunized, your threat of getting this infection or passing it on is low, which is why it stated masks are not required inside or outdoors, if you are fully immunized,” Murthy said. Authorized vaccines from Moderna, Pfizer-BioNTech and Johnson & & Johnson have actually shown to be highly efficient in avoiding Covid, especially versus extreme illness and death.
- Covid transmission common in pet cats and dogs – BBC News
- California’s COVID-19 cases rising as delta variant spreads – KTLA Los Angeles